• Clinical Associate Professor, Global Health
Wubshet Mamo

International Training and Education Center on Health (I-TECH)
Phone: (251) 911 821 624

Select from the following:

Dr Wubshet Mamo (DVM, MVSc, PhD), is Associate Professor of Medical Microbiology (UU, Sweden), Clinical Associate Professor (Faculty) –at UW-GHD, long experience working with UW-GHD-I-TECH, as Clinical laboratory program Director in Ethiopia, as Global Health Consultant for UW-I-TECH, MSH/USAID supporting in establishing Regulatory Science Master’s program in Ethiopia, for ASM, CDC, GHSA, EPHI (PEPFAR) establishing national AMR surveillance strategic plan in Ethiopia. Dr Mamo is a Program Manager at ASLM (African Society for Laboratory Medicine) managing health system strengthening programs/projects such as, clinical quality improvement, improving quality management system (QMS) of clinical laboratories towards ISO 15189 and accreditation, HIV testing, treatment and care, Viral load roll outs and HIV drug resistant testing quality improvement, including professional skill building, leadership and management in Africa, (Botswana, Tanzania), Caribbean countries (Jamaica, Trinidad & Tobago, Suriname, Guyana, Bahamas, Barbados, St. Lucia, St. Vincent, St. Kitts, Antigua, Dominica, Grenada) and Papua New Guinea.

Dr Mamo has over 10 years of experience in the field of health system strengthening/health development, as Director and Senior Manager in Africa. Dr Mamo has long experiences working within HIV/AIDS diagnosis, care and treatment programs, TB diagnosis, prevention and control, maternal neonatal & child health (MNCH /PMTCT) and pediatric HIV program, clinical (laboratory) quality improvement towards international standards (ISO), leading PHC program through integrated urban development program and building the capacity of community based organizations on prevention of HIV/AIDS and PMTCT and implementation of health development programs within a global health context in resource limited settings.

Dr Mamo has extensive experience in biomedical (basic, applied and transitional), preclinical research and research project management, 14 years of experience in R & D drug discovery project management in global pharmaceutical company (AstraZeneca, Sweden) trying to develop therapies for GI, CNS (Alzheimer, Stroke, Multiple Sclerosis, Parkinson) diseases. He has contributed to the discovery of some human therapeutic medicines. Dr Mamo has long experience in teaching (lecturer) medical and vet Microbiology. He is an experienced veterinarian centering small animal infections, prophylactic vaccines, zoonotic diseases and “One Health” approach.

For more information about Dr. Mamo, visit his LinkedIn page here

  • PhD (Swedish University)
  • DVM (Kharkov State Veterinary Academy)
  • MVSc (Kharkov State Veterinary Academy)
  • Amharic
  • French
  • Russian
  • Spanish
  • Swedish
Health Topics 
  • Disease Surveillance
  • Distance Learning
  • Drug and Vaccine Development
  • Ebola
  • Environmental Health (incl. Climate Change)
  • Health Information Systems
  • Health Interventions
  • Host-pathogen Interactions
  • Immunizations
  • Infectious Diseases (other than STDs)
  • Injury, Violence, Trauma and Domestic Violence
  • Laboratory Strengthening
  • Leadership and Organizational Development
  • Male Circumcision
  • Mental Health
  • Pathogenesis
  • Zoonotic Diseases and Animal Health

Peter Fonjungo, Mamo, W, et al. (2013). Field expansion of DNA polymerase chain reaction for early in- fant diagnosis of HIV-1: The Ethiopian experience. African Journal of Laboratory Medicine, Vol 2, No 1, 2013

Mamo, W., Fröman G. and Müller, H-P. (2000). Protection induced in mice vaccinated with recombinant Collagen-binding protein (CnBP) and alpha-toxoid against intramammary infection with S.aureus. Micro- biology & Immunology, 44:5:381-384.

Mamo, W., Jonsson, P. and Müller, H-P. (1995). Opsonization of S.aureus with a fibronectin-binding pro- tein antiserum induces protection in mice. Microb. Pathogen, 19:49-55.

Mamo, W., Bodén, M. and Flock, J-I. (1994). Vaccination with S.aureus fibrinogen-binding proteins (FbBPs) reduces colonization of S. aureus in a mouse mastitis model. FEMS Immunol. and Medical Mi- crobiol. 10:47-54.

Mamo, W., Jonsson, P., Flock, J-I., Lindberg, M., Müller, H. P., Wadström, T. and Nelson, L. (1994). Vac- cination against S. aureus mastitis: Immunological response of mice vaccinated with fibronectin-binding proteins (FnBps) to challenge with S. aureus. Vaccine, 12:11:988-992